Trial Profile
A trial to study the genetic variation in sex hormone receptor genes and association with enzalutamide response in metastatic castration-resistant prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2016
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 17 Aug 2016 New trial record